BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9144496)

  • 1. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
    Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
    J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
    Louis-Plence P; Moreno CS; Boss JM
    J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X box-like sequences in the MHC class II region maintain regulatory function.
    Gomez JA; Majumder P; Nagarajan UM; Boss JM
    J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes.
    Hake SB; Tobin HM; Steimle V; Denzin LK
    Eur J Immunol; 2003 Sep; 33(9):2361-71. PubMed ID: 12938212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.
    Ting JP; Wright KL; Chin KC; Brickey WJ; Li G
    J Immunol; 1997 Dec; 159(11):5457-62. PubMed ID: 9548486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.
    Kern I; Steimle V; Siegrist CA; Mach B
    Int Immunol; 1995 Aug; 7(8):1295-9. PubMed ID: 7495736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
    Taxman DJ; Cressman DE; Ting JP
    J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants.
    Chin KC; Li G; Ting JP
    J Immunol; 1997 Sep; 159(6):2789-94. PubMed ID: 9300700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene.
    Brown AM; Barr CL; Ting JP
    J Immunol; 1991 May; 146(9):3183-9. PubMed ID: 1901895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
    Hasegawa SL; Riley JL; Sloan JH; Boss JM
    J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
    Brickey WJ; Wright KL; Zhu XS; Ting JP
    J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes.
    Siegrist CA; Mach B
    Eur J Immunol; 1993 Nov; 23(11):2903-8. PubMed ID: 8223867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.